Effects of ethanol and other constituents of alcoholic beverages on coronary heart disease: a review

Heberden, 1772, Some account of a disorder of the breast, Med. Transact. College Physicians, 2, 59 Cabot, 1904, The relationship of alcohol to arteriosclerosis, JAMA, 43, 774, 10.1001/jama.1904.92500120002a Boffetta, 1990, Alcohol drinking and mortality among men enrolled in an American Cancer Society prospective study, Epidemiology, 1, 342, 10.1097/00001648-199009000-00003 Kannel, 1996, Alcohol and coronary heart disease: the evidence for a protective effect, Clin. Chim. Acta, 246, 59, 10.1016/0009-8981(96)06227-4 Moore, 1986, Moderate alcohol consumption and coronary artery disease: a review, Medicine (Baltimore), 65, 242, 10.1097/00005792-198607000-00004 Rimm, 1996, Alcohol consumption and coronary heart disease: good habits may be more important than just good wine, Am. J. Epidemiol., 143, 1094, 10.1093/oxfordjournals.aje.a008684 Kauhanen, 1999, Pattern of alcohol drinking and progression of atherosclerosis, Arterioscler. Thromb. Vasc. Biol., 19, 3001, 10.1161/01.ATV.19.12.3001 Rimm, 1996, Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits, BMJ, 312, 731, 10.1136/bmj.312.7033.731 Mukamal, 2003, Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men, N. Engl. J. Med., 348, 109, 10.1056/NEJMoa022095 Rimm, 2001, Alcohol and coronary heart disease: can we learn more?, Epidemiology, 12, 380, 10.1097/00001648-200107000-00006 J. Folts, 2002. Potential health benefits from the flavonoids in grape products on vascular disease, in: B. Buslig, J.A. Manthey (Eds.), Flavonoids in Cell Function, Kluwer Academic Publishers, New York, pp. 95–111. J.A. Vita, J.F. Keaney, J. Loscalzo, Endothelial dysfunction in vascular disease, in: J. Loscalzo, M.A. Creager, V.J. Dzau (Eds.), Vascular Medicine: A Textbook of Vascular Biology and Diseases, vol. 9, Little Brown, Boston, 1996, pp. 245–246. Solzbach, 1997, Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients, Circulation, 96, 1513, 10.1161/01.CIR.96.5.1513 Cooke, 1990, Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol, Am. J. Physiol., 259, H804 Ting, 1997, Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia, Circulation, 95, 2617, 10.1161/01.CIR.95.12.2617 Fitzpatrick, 1993, Endothelium-dependent vasorelaxing activity of wine and other grape products, Am. J. Physiol., 265, H774 Flesch, 1998, Effects of red and white wine on endothelium-dependent vasorelaxation of rat aorta and human coronary arteries, Am. J. Physiol., 275, H1183 Dong, 1995, Inhibitory effect of alcohol on cyclic GMP accumulation in human platelets, Thromb. Res., 80, 143, 10.1016/0049-3848(95)00160-S Andriambeloson, 1999, Mechanism of endothelial nitric oxide-dependent vasorelaxation induced by wine polyphenols in rat thoracic aorta, J. Cardiovasc. Pharmacol., 33, 248, 10.1097/00005344-199902000-00011 Rubanyi, 1986, Flow-induced release of endothelium-derived relaxing factor, Am. J. Physiol., 250, H1145 B. Takase, A. Uehata, T. Akima, T. Nagai, T. Nishioka, A. Hamabe, K. Satomura, F. Ohsuzu, A. Kurita, Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease. Am J Cardiol 82 (12) (1998) 1535–1539, A7–A8. Stein, 1999, Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease, Circulation, 100, 1050, 10.1161/01.CIR.100.10.1050 Hashimoto, 2001, Effect of acute intake of red wine on flow-mediated vasodilatation of the brachial artery, Am. J. Cardiol., 88, 1457, 10.1016/S0002-9149(01)02137-3 Cuevas, 2000, A high-fat diet induces and red wine counteracts endothelial dysfunction in human volunteers, Lipids, 35, 143, 10.1007/BF02664763 Ross, 1993, The pathogenesis of atherosclerosis: a perspective for the 1990s, Nature, 362, 801, 10.1038/362801a0 Navab, 1996, The Yin and Yang of oxidation in the development of the fatty streak, Arterioscler. Thromb. Vasc. Biol., 16, 831, 10.1161/01.ATV.16.7.831 Diaz, 1997, Antioxidants and atherosclerotic heart disease, N. Engl. J. Med., 337, 408, 10.1056/NEJM199708073370607 Holvoet, 1998, Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis, Atherosclerosis, 137, S33, 10.1016/S0021-9150(97)00305-5 Gaziano, 1993, Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction, N. Engl. J. Med., 329, 1829, 10.1056/NEJM199312163292501 Cook, 1996, Flavonoids—chemistry, metabolism, cardioprotective effects, and dietary sources, Nutr. Biochem., 7, 66, 10.1016/0955-2863(95)00168-9 J.A. Vinson, Flavonoids in foods as in vitro and in vivo antioxidants, in: J.A. Manthey, B. Buslig (Eds.), Flavonoids in the Living System, vol. 11, Plenum Press, New York, 1998, pp. 151–164. Frankel, 1993, Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine, Lancet, 341, 454, 10.1016/0140-6736(93)90206-V Frankel, 1995, Principal phenolic phytochemicals in selected California wines and thier antioxidant activity in inhibiting oxidation of human low-density lipoproteins, J. Agric. Food Chem., 43, 890, 10.1021/jf00052a008 Nigdikar, 1998, Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo, Am. J. Clin. Nutr., 68, 258, 10.1093/ajcn/68.2.258 Fuhrman, 1995, Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation, Am. J. Clin. Nutr., 61, 549, 10.1093/ajcn/61.3.549 de Gaetano, 2001, Wine and cardiovascular disease, Nutr. Metab. Cardiovasc. Dis., 11, 47 Rifici, 1999, Red wine inhibits the cell-mediated oxidation of LDL and HDL, J. Am. Coll. Nutr., 18, 137, 10.1080/07315724.1999.10718841 Nordmann, 1994, Alcohol and antioxidant systems, Alcohol Alcohol., 29, 513 Rubin, 1994, Alcohol and platelet function, Alcohol Clin. Exp. Res., 18, 105, 10.1111/j.1530-0277.1994.tb00888.x Mikhailidis, 1990, The effect of ethanol on platelet function and vascular prostanoids, Alcohol, 7, 171, 10.1016/0741-8329(90)90080-V Folts, 1976, Platelet aggregation in partially obstructed vessels and its elimination with aspirin, Circulation, 54, 365, 10.1161/01.CIR.54.3.365 S. Sherry, Aspirin and Antiplatelet Drugs: The Clinical Approach, CVR & R, December 1991, pp. 11–19. Folts, 1995, Drugs for the prevention of coronary thrombosis: from an animal model to clinical trials, Cardiovasc. Drugs Ther., 9, 31, 10.1007/BF00878571 Keller, 1988, Relative effects of cigarette smoke and ethanol on acute platelet thrombus formation in stenosed canine coronary arteries, Cardiovasc. Res., 22, 73, 10.1093/cvr/22.1.73 Demrow, 1995, Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries, Circulation, 91, 1182, 10.1161/01.CIR.91.4.1182 Begolli, 1996, Gastric administration of dark but not light colored beer inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries, FASEB, 10, A43 Shanmuganayagam, 2001, Effect of polyphenolic flavonoid compounds on platelets, Methods Enzymol., 335, 369, 10.1016/S0076-6879(01)35259-X Folts, 1998, Antithrombotic potential of grape juice and red wine for preventing heart attacks, Pharm. Biol., 36, S21, 10.1076/phbi.36.6.21.4558 Seigneur, 1990, Effect of the consumption of alcohol, white wine and red wine on platelet function and serum lipids, J. Appl. Cardiol., 5, 215 Tzeng, 1991, Inhibition of platelet aggregation by some flavonoids, Thromb. Res., 64, 91, 10.1016/0049-3848(91)90208-E Renaud, 1992, Wine, alcohol, platelets, and the “French paradox” for coronary heart disease, Lancet, 339, 1523, 10.1016/0140-6736(92)91277-F Pellegrini, 1996, Effects of moderate consumption of red wine on platelet aggregation and haemostatic variables in healthy volunteers, Eur. J. Clin. Nutr., 50, 209 Wollny, 1999, Modulation of haemostatic function and prevention of experimental thrombosis by red wine in rats: a role for increased nitric oxide production, Br. J. Pharmacol., 127, 747, 10.1038/sj.bjp.0702586 Iijima, 2002, Red wine polyphenols inhibit vascular smooth muscle cell migration through two distinct signaling pathways, Circulation, 105, 2404, 10.1161/01.CIR.0000016349.36385.FB Rosenkranz, 2002, Inhibition of the PDGF receptor by red wine flavonoids provides a molecular explanation for the “French paradox”, FASEB J., 16, 1958, 10.1096/fj.02-0207fje Blanco-Colio, 2000, Red wine intake prevents nuclear factor-kappaB activation in peripheral blood mononuclear cells of healthy volunteers during postprandial lipemia, Circulation, 102, 1020, 10.1161/01.CIR.102.9.1020 D. Gross, Animal Models in Cardiovascular Research, Nijhoff, Boston, 1985, p. 616. Bocan, 1998, Animal models of atherosclerosis and interpretation of drug intervention studies, Curr. Pharm. Des., 4, 37 Klurfeld, 1981, Differential effects of alcoholic beverages on experimental atherosclerosis in rabbits, Exp. Mol. Pathol., 34, 62, 10.1016/0014-4800(81)90036-8 Vinson, 2001, Red wine, dealcoholized red wine, and especially grape juice, inhibit atherosclerosis in a hamster model, Atherosclerosis, 156, 67, 10.1016/S0021-9150(00)00625-0